Publication | Closed Access

SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition

Autoimmune DiseaseImmunologyPathologyCancer GenomicsImmune Checkpoint InhibitorAutoimmunityClinicopathologic CharacteristicsImmunotherapyMedicineInborn Error Of ImmunityTumor BiologyImmune Checkpoint Inhibition